Tham khảo Bifluranol

  1. ↑ J. Elks (ngày 14 tháng 11 năm 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. tr. 152. ISBN 978-1-4757-2085-3.
  2. ↑ Index Nominum 2000: International Drug Directory. Taylor & Francis. tháng 1 năm 2000. tr. 124–. ISBN 978-3-88763-075-1.
  3. 1 2 3 4 Dekanski, J.B. (1980). “Anti-prostatic activity of bifluranol, a fluorinated bibenzyl”. British Journal of Pharmacology. 71 (1): 11–16. doi:10.1111/j.1476-5381.1980.tb10903.x. ISSN 0007-1188. PMC 2044395. PMID 6258683.
  4. 1 2 Pope, D. J.; Gilbert, A. P.; Easter, D. J.; Chan, R. P.; Turner, J. C.; Gottfried, S.; Parke, D. V. (1981). “Bifluranol, a novel fluorinated bibenzyl anti-androgen, its chemistry and disposition in different animal species”. Journal of Pharmacy and Pharmacology. 33 (1): 297–301. doi:10.1111/j.2042-7158.1981.tb13784.x. ISSN 0022-3573. PMID 6116777.
  5. ↑ Beacock, C. J. M.; Buck, A. C.; Roberts, E. E. (1985). “Bifluranol in the treatment of benign prostatic hyperplasia (BPH)”. The Prostate. 7 (4): 357–361. doi:10.1002/pros.2990070403. ISSN 0270-4137.
  6. ↑ Keane, P. F.; Timoney, A. G.; Kiely, E.; Williams, Gordon; Stamp, G. (1988). “Response of the Benign Hypertrophied Prostate to Treatment with an LHRH Analogue”. British Journal of Urology. 62 (2): 163–165. doi:10.1111/j.1464-410X.1988.tb04299.x. ISSN 0007-1331. PMID 2457404.
  7. 1 2 Spain. Ministerio de Agricultura; Universidad Complutense de Madrid. Departamento de Genetico y Mejora (1978). 3rd World Congress of Animal Feeding. Industrias Gráficas España. tr. 532. ISBN 978-84-7391-022-4.
  8. ↑ Annual Reports in Medicinal Chemistry. Academic Press. ngày 16 tháng 9 năm 1986. tr. 182–. ISBN 978-0-08-058365-5.
  9. ↑ M. K. Agarwal (1987). Receptor mediated antisteroid action. De Gruyter. tr. 330. ISBN 978-0-89925-374-9.
  10. ↑ Barrie, S.E.; Rowlands, M.G.; Foster, A.B.; Jarman, M. (1989). “Inhibition of 17α-hydroxylase/C17-C20 lyase by bifluranol and its analogues”. Journal of Steroid Biochemistry. 33 (6): 1191–1195. doi:10.1016/0022-4731(89)90429-9. ISSN 0022-4731. PMID 2559252.
  11. ↑ Jarman, Michael; John Smith, H.; J. Nicholls, Paul; Simons, Claire (1998). “Inhibitors of enzymes of androgen biosynthesis: cytochrome P45017α and 5α-steroid reductase”. Natural Product Reports. 15 (5): 495. doi:10.1039/a815495y. ISSN 0265-0568.
  12. ↑ Barrie, S.E.; Haynes, B.P.; Potter, G.A.; Chan, F.C.Y.; Goddard, P.M.; Dowsett, M.; Jarman, M. (1997). “Biochemistry and pharmacokinetics of potent non-steroidal cytochrome P45017α inhibitors”. The Journal of Steroid Biochemistry and Molecular Biology. 60 (5–6): 347–351. doi:10.1016/S0960-0760(96)00225-7. ISSN 0960-0760.
  13. ↑ Polska Akademia Nauk. Komitet Badania Polonii (1984). II Kongres Uczonych Polskiego Pochodzenia: zbiór materiałów. Zakład Narodowy im. Ossolińskich. ISBN 978-83-04-01670-5. [This explains why the estrogenic activity is minimal in terms of pentafluranol or even bifluranol. Doses which shall apply from 1 to 6 days of pregnancy, are in micrograms per kg of body weight: bifluranol 80, 30 and terfluranol pentafluranol 280...]